Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Hematopoiesis01:21

Hematopoiesis

5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
731
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drives.

Haematologica·2026
Same author

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

Cancer science·2026
Same author

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

Nature communications·2026
Same author

Validation of ICC hierarchical classification in secondary AML.

Blood advances·2026
Same author

Multi-modal AI in precision medicine: integrating genomics, imaging, and EHR data for clinical insights.

Frontiers in artificial intelligence·2026
Same author

IDH1 mutation in acute lymphoblastic leukemia-A rare but significant finding.

Current research in translational medicine·2025

Related Experiment Video

Updated: Jul 1, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.2K

TET2 mutation as prototypic clonal hematopoiesis lesion.

Luca Guarnera1, Babal K Jha2

  • 1Department of Biomedicine and Prevention, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

Seminars in Hematology
|March 2, 2024
PubMed
Summary

Loss of function TET2 mutations drive clonal hematopoiesis by altering DNA methylation, impacting cell differentiation and promoting myeloid malignancies. This review explores TET2 biology, its link to aging and inflammation, and therapeutic strategies for TET2-mutated CHIP.

Keywords:
AgingCHIPEpigeneticsInflammationTET2TargetingTherapeutic development

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.5K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.4K

Related Experiment Videos

Last Updated: Jul 1, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.2K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.5K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.4K

Area of Science:

  • Hematopoiesis and Cancer Biology
  • Epigenetics and DNA Methylation Dynamics
  • Aging and Inflammation Research

Background:

  • Loss-of-function TET2 mutations (TET2MT) are prevalent in clonal hematopoiesis (CH), a condition linked to aging and increased cancer risk.
  • TET2 enzymes regulate DNA demethylation, crucial for gene transcription, cell lineage determination, proliferation, and genomic stability.
  • TET2MT leads to aberrant DNA methylation, causing skewed myeloid differentiation, impaired hematopoietic stem and progenitor cell (HSPC) function, and clonal expansion.

Approach:

  • Review of recent advancements in TET2 biology, focusing on its role in CH pathogenesis.
  • Exploration of the mechanistic links between TET2 loss, aging, and chronic inflammation.
  • Analysis of emerging therapeutic strategies targeting TET2MT-associated CHIP and normal hematopoiesis.

Key Points:

  • TET2MT clones exhibit a competitive advantage, dominating during stress hematopoiesis and often preceding myeloid malignancies.
  • These mutant clones thrive in pro-inflammatory environments, suggesting a critical interplay between inflammation and TET2-driven pathogenesis.
  • Understanding the biochemical mechanisms of TET2 dysfunction is key to deciphering CHIP's complex pathology.

Conclusions:

  • TET2MT is a central driver in CHIP, affecting myeloid differentiation and HSPC behavior through epigenetic dysregulation.
  • Further research into TET2's role in aging and inflammation is crucial for developing effective therapies.
  • Targeting TET2 presents a promising avenue for treating CHIP and potentially for applications in normal hematopoiesis and somatic cell reprogramming.